Pharmacodynamics and Clinical Studies with Beraprost Sodium, a Drug for Peripheral Vascular Disease

This publication has 21 references indexed in Scilit:

• Cytoprotective effect of TRK-100, a prostacyclin analogue, against chemical injuries in cultured human vascular endothelial cells
  Life Sciences, 1989
• Effect of TRK-100, a prostacyclin analogue, on endotoxin-induced enhancement of blood coagulation in rats.
  The Japanese Journal of Pharmacology, 1989
• Diabetes-induced enhancement of prostanoid-stimulated contraction in mesenteric veins of mice.
  The Japanese Journal of Pharmacology, 1989
• Effect of PGI2 analogue (TRK-100) on haemorheological factors in patients with peripheral vascular disease.
  Blood & Vessel, 1989
• Phase i study of beraprost sodium (TRK-100), a prostacyclin derivative - Repeated oral administration study for 10 days.
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1989
• Phase i study of beraprost sodium (TRK-100), a prostacyclin derivative-Single oral administration study.
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1989
• Cardiovascular effects of beraprost sodium (TRK-100), a prostacyclin analogue in the dog.
  Folia Pharmacologica Japonica, 1989
• Beraprost Sodium
  Cardiovascular Drug Reviews, 1988
• Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue.
  The Japanese Journal of Pharmacology, 1987
• The effect of prostacyclin on platelet aggregation and disaggregation
  Thrombosis Research, 1980